Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Zomedica vs. Elanco: Which Pet Stock Is a Better Buy?

Published 06/08/2021, 06:17 PM
Updated 06/08/2021, 07:30 PM
© Reuters.  Zomedica vs. Elanco: Which Pet Stock Is a Better Buy?

© Reuters. Zomedica vs. Elanco: Which Pet Stock Is a Better Buy?

Zomedica (ZOM) and Elanco (ELAN) are companies within the pet healthcare industry. While one is in the development stage the other is an established player. The pet industry all over the world continues to expand making the two companies enticing bets for 2021 and beyond but which one is a better buy now?.Several industries have benefited from the COVID-19 pandemic as people were confined to their homes and entertainment options were limited. Companies part of the e-commerce, streaming, gaming, and streaming vertical saw a massive uptick in consumer demand.

Another space that significantly benefited from the coronavirus lockdown was the pet industry. More than 11 million U.S. households were estimated to have gotten a new pet during the pandemic. This trend acted as a secular driver for pet healthcare companies.

Here, we take a look at two companies part of the pet healthcare industry, Zomedica (ZOM) and Elanco (ELAN), to analyze which is a better stock right now.

Continue reading on StockNews

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.